Erin Dunston, Matt Fedowitz and Jon Janow will present a CLE webinar that will guide counsel on pharmaceutical-related patent challenges from strategy to settlement. The panel will discuss the interplay between Paragraph IV litigation and post-grant proceedings, and where multiple generic challengers fit in the exclusivity scheme. The presenters will also examine critical issues in Inter partes review (IPR) challenges involving pharmaceutical patents. Finally, the presenters will discuss new risks to settlement in light of the changing landscape surrounding antitrust review of pharmaceutical patent settlements.
The webinar will be on Tuesday, March 31, 2020 from 1 - 2:30 p.m. Early Registration Discount Deadline, Friday, March 13, 2020.
